.
BUDGET 2012
 | News | Market | Portfolio | Messages
SENSEX  26,087.42  96.19
NIFTY  7,791.40  42.70
Go to Moneycontrol Home
Pharmaceuticals
Biocon Q1 net up 9% to Rs 103 crore
Biocon had posted a net profit of Rs 94 crore during the same period of previous fiscal. The total revenue of the compan
Strides Arcolab Q1 net rises 12 times to Rs 26.8 cr
R&D spends expected to increase significantly: Biocon
Glenmark retains FY15 sales target; to launch 8 pdts in US
Ranbaxy inks pact with Cipher to sell acne drug in Brazil
Sanofi Q2 net up 12.30% at Rs 57.5 crore
How new price control list impacts Indian pharma cos
STOCK RECOMMENDATION
Stock Advice
Buy Dr Reddy's Labs, Indiabulls Housing, HCL Tech: Joshi
Ranbaxy Laboratories may test Rs 610-615: Hemant Thukral
Buy Lupin, says Sudarshan Sukhani
more
Broker Reports
Buy Ipca Labs; target of Rs 930: Motilal Oswal
Hold Glenmark Pharma; target of Rs 670: Sharekhan
Buy Glenmark Pharma; target of Rs 725: Religare Capital
more
Budget 2012
HOME
Font Size: S M L
Mobile | Classic
Customer Support
© 2011. a Web18 Venture